Overview

Comparison of Sirolimus and Azathioprine in Lung Transplantation

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and effectiveness of two different anti-rejection drug regimens.
Phase:
Phase 4
Details
Lead Sponsor:
University of Chicago
Collaborators:
Astellas Pharma Inc
Baylor College of Medicine
Columbia University
Loyola University
Ochsner Health System
University of Florida
University of Pennsylvania
University of Wisconsin, Madison
Treatments:
Azathioprine
Everolimus
Prednisone
Sirolimus
Tacrolimus